Since September 2015 the Darmstadt-based diagnostic company R-Biopharm AG is a new partner of InfectoGnostics Research Campus. The medium-sized company is the first InfectoGnostics partner outside of Thuringia.
The aim of the partnership is a close cooperation in the fields of clinical diagnostics and water analytics. Furthermore R-Biopharm is contributing its marketing expertise into the public-private partnership.
„We want to strengthen the transfer from research results to marketable products“, says Dr. Frank Apostel, Vice President Companion Diagnostics at R-Biopharm. „The innovation oriented campus structure of InfectoGnostics and the existing network of technology, application and production are ideal conditions for us.“
Professor Jürgen Popp, managing board spokesman of InfectoGnostics adds: „R-Biopharm is well known as a reliable project partner and we are looking forward to working with them on diagnostic solutions within the research campus.”
About InfectoGnostics – Research Campus Jena
The InfectoGnostics research campus is a public-private partnership developing new methods in infection diagnostics, e. g. viruses, bacteria and fungi. InfectoGnostics is supported by the German Federal Ministry of Education and Research within the funding initiative “Research campus – Public-private Partnership for Innovation” and with additional funding by the Land of Thuringia. Half of the budget is financed by the InfectoGnostics partners.